FEATURE ARTICLES
In one area, the Initiative for New Manufacturing is exploring whether microfactories, championed by the EV industry, can help biopharma iterate facility design faster.
- Rethinking Product Development Through Lipid-Based Formulations
- What To Know About — And How To Apply For — FDA's PreCheck Pilot
- MES Is Still In The CD ROM Era But The Data Architecture Has Moved On
- The Rise Of The Autonomous Pharma Plant
- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact
- A Peek Into Novo Nordisk's Sustainable Facility Construction Mindset
- At Base Camp: Lilly's Manufacturing Capacity Journey
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-2036497698 clinical lab]( "Molecular Properties Of PROTACs And The Relationship To Formulation Design")
Molecular Properties Of PROTACs And The Relationship To Formulation DesignHere, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
-
Performance Characteristics Of The Mobius® ADC Reactor For Conjugation10/22/2024
Explore results from a series of studies evaluating the mixing performance of an innovative ADC reactor during the conjugation step utilizing a model fluid.
-
Improving Gene Therapy Development With Organ-On-A-Chip Technology8/7/2024
Explore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.
-
Streamline Your mAb Manufacturing With Strategic Development And CDMO Compatibility6/4/2025
Though the journey to mAb development begins at lab scale, for clinical trials and commercial distribution, a production process must be streamlined and scalable to 2,000 L production and above.
-
The Evolution Of Antibody-Drug Manufacturing6/3/2024
Explore how ADC chemistry and manufacturing have evolved, the challenges this dynamic growth has created, and how CDMOs are adapting to these changes to meet customer needs, now and in the future.
-
Extended Head Flats Increase Dwell Time4/25/2024
Explore the extended head flat and how this punch modification can improve the compression of difficult formulations.
PHARMA ONLINE APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
- 03.10.26 -- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact
- 03.10.26 -- Modernizing CCI: Why Deterministic Risk‑Based Testing Is Now Essential
- 03.07.26 -- Facilities And Cleanrooms Product Showcase
- 03.06.26 -- Rethinking Product Development Through Lipid-Based Formulations
- 03.05.26 -- STREAM Edition: Addressing The Business Side Of GLP-1 Manufacturing
INDUSTRY NEWS
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Forma Life Sciences Launches U.S. Based Contract Development And Manufacturing Organization (CDMO) For Oral Solid Dosage Development And Commercial Manufacturing In Irvine, California3/6/2026
Forma Life Sciences, Inc. today announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product manufacturing in the United States.
-
Join Esco At INTERPHEX 20263/3/2026
-
Ensorcell Appoints Biopharma Industry Veterans Geoff Hodge And Amy Teachout To Senior Leadership Team3/3/2026
Ensorcell, a company focused on reimaging life science tools and solutions for the biopharmaceutical industry, today announced the appointment of Geoff Hodge and Amy Teachout to its senior leadership team. These appointments reinforce Ensorcell’s commitment to innovation, superb value, and exceptional customer experience as the company continues to expand its capabilities and partnerships across the biopharma ecosystem.
-
Novartis Announces New Radioligand Therapy Manufacturing Facility In Denton, Texas2/26/2026
Novartis, a leading global innovative medicines company, today announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, Texas.
